Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. S. (Sandy) Schmidt

Research interests

The research of Prof. Dr. S. Schmidt exploits the powerful reactivity and selectivity of enzymes from secondary metabolite pathways for the production of natural products and their analogs for pharmaceutical applications. One of the main areas of interest is the identification, characterization and the engineering of Rieske non-heme iron oxygenases for their application in biocatalytic reactions towards pharmaceuticals and/or precursors thereof. Along this line, the outstanding reactivities of these biocatalysts are exploited in synthetic metabolic pathways and (chemo)enzymatic cascade reactions for the production of complex compounds from simple precursors. The Schmidt group is thereby using state-of-the-art synthetic biology tools for the design and assembly of artificial metabolic pathways, and is developing new methodologies for the genetic engineering of several chassis strains. Finally, the Schmidt group aims at the development of new concepts for electron transfer pathways in microorganisms, and is developing concepts to optimize electron transfer chains in multi-component oxidoreductases. By expanding our knowledge on the parameters determining efficient electron transfer and thus catalysis, it is expected that this will increase the broad applicability of multi-component oxidoreductases relying on complex electron transfer mechanisms.

Publicaties

Cell-free chemoenzymatic cascades with bio-based molecules

Developing hybrid systems to address oxygen uncoupling in multi-component Rieske oxygenases

Enhancing biocatalytical N-N bond formation with the actinobacterial piperazate synthase KtzT

In vitro analysis of the three-component Rieske oxygenase cumene dioxygenase from Pseudomonas fluorescens IP01

Light-driven bioprocesses

Light-driven bioprocesses

Protein fusion strategies for a multi-component Rieske oxygenase

Recent Developments and Challenges in the Enzymatic Formation of Nitrogen–Nitrogen Bonds

Using Cupriavidus necator H16 to provide a roadmap for increasing electroporation efficiency in non-model bacteria

Using Cupriavidus necator H16 to Provide a Roadmap for Increasing Electroporation Efficiency in Nonmodel Bacteria

Lees meer

Pers/media

Bodembacterie maakt eiwitten en geneesmiddelen uit kooldioxide

Herausgeber des RÖMPP - Thieme Chemistry - Georg Thieme Verlag

RUG onderzoeker ontdekt ‘superbacterie’ die schadelijk CO2 omzet in geneesmiddelen

In Groningen gemanipuleerde bacterie ‘maakt kaas en medicijnen van CO2’

Soil bacteria produce proteins from carbon dioxide

Sandy Schmidt awarded ERC Starting Grant

Sandy Schmidt awarded NWO Vidi grant

Lees meer